It may be that other metabolic-modulating cytokines, such as IL-7, IL-15, or IL-10 could be altering glycolysis and the subsequent effector functions in ME/CFS [147]. This evidence concerns the gene IL10 and myalgic encephalomeyelitis/chronic fatigue syndrome.